Chong P, Higashi K, Matsuoka W, Arimura K, Sangatsuda Y, Iwaki K
BMC Neurol. 2024; 24(1):17.
PMID: 38166683
PMC: 10759412.
DOI: 10.1186/s12883-023-03493-z.
Tiwari S, Garg P, Panda S, Gupta A, Hegde A, Kumar D
Indian J Radiol Imaging. 2023; 33(3):351-360.
PMID: 37362355
PMC: 10289858.
DOI: 10.1055/s-0043-1768060.
Negro A, Tortora M, Gemini L, De Falco A, Somma F, DAgostino V
Acta Radiol. 2022; 64(5):1950-1957.
PMID: 36451533
PMC: 9720471.
DOI: 10.1177/02841851221138557.
Khan D, Naderi S, Ahmadi M, Ghorbani A, Cornelius J, Hanggi D
Pathogens. 2022; 11(6).
PMID: 35745471
PMC: 9227511.
DOI: 10.3390/pathogens11060617.
Hira K, Ueno Y, Miyamoto N, Nakajima S, Kijima C, Hattori N
BMC Neurol. 2022; 22(1):128.
PMID: 35382754
PMC: 8980204.
DOI: 10.1186/s12883-022-02657-7.
The relationship between COVID-19 infection and intracranial hemorrhage: A systematic review.
Daly S, Nguyen A, Zhang Y, Feng D, Huang J
Brain Hemorrhages. 2021; 2(4):141-150.
PMID: 34786548
PMC: 8582085.
DOI: 10.1016/j.hest.2021.11.003.
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W, Mead H, Tian L, Park J, Garcia J, Jaramillo S
J Virol. 2021; 96(1):e0096421.
PMID: 34668775
PMC: 8754221.
DOI: 10.1128/JVI.00964-21.
The significant impact of Coronavirus disease 2019 (COVID-19) on in-hospital mortality of elderly patients with moderate to severe traumatic brain injury: A retrospective observational study.
Bagheri S, Abdi A, Benson J, Naghdi N, Eden S, Arjmand M
J Clin Neurosci. 2021; 93:241-246.
PMID: 34656255
PMC: 8462266.
DOI: 10.1016/j.jocn.2021.09.029.
COVID-19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations.
Ghorbani M, Lafta G, Rahbarian F
Clin Case Rep. 2021; 9(10):e04893.
PMID: 34631077
PMC: 8489393.
DOI: 10.1002/ccr3.4893.
Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.
Jesuthasan A, Massey F, Manji H, Zandi M, Wiethoff S
J Neurol Sci. 2021; 428:117608.
PMID: 34391037
PMC: 8332920.
DOI: 10.1016/j.jns.2021.117608.
Coexistence of neurological diseases with Covid-19 pneumonia during the pandemic period.
Gorgulu U, Bayindir H, Bektas H, Kayipmaz A, San I
J Clin Neurosci. 2021; 91:237-242.
PMID: 34373034
PMC: 8257424.
DOI: 10.1016/j.jocn.2021.06.041.
SARS-CoV-2 and Acute Cerebrovascular Events: An Overview.
Ghasemi M, Pizzolato Umeton R, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N
J Clin Med. 2021; 10(15).
PMID: 34362133
PMC: 8348889.
DOI: 10.3390/jcm10153349.
Intracranial Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series.
Abbas R, El Naamani K, Sweid A, Schaefer J, Bekelis K, Sourour N
World Neurosurg. 2021; 154:e473-e480.
PMID: 34298138
PMC: 8294594.
DOI: 10.1016/j.wneu.2021.07.067.
Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.
Owolabi L, Raafat A, Enwere O, Mustapha A, Adamu B, Alghamdi M
J Community Hosp Intern Med Perspect. 2021; 11(3):322-326.
PMID: 34191990
PMC: 8108187.
DOI: 10.1080/20009666.2021.1883814.
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories.
Manca R, De Marco M, Ince P, Venneri A
Front Aging Neurosci. 2021; 13:646908.
PMID: 34149394
PMC: 8209297.
DOI: 10.3389/fnagi.2021.646908.
The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients.
Alonso-Bellido I, Bachiller S, Vazquez G, Cruz-Hernandez L, Martinez E, Ruiz-Mateos E
Front Aging Neurosci. 2021; 13:632673.
PMID: 33889082
PMC: 8055831.
DOI: 10.3389/fnagi.2021.632673.
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review.
Venketasubramanian N, Anderson C, Ay H, Aybek S, Brinjikji W, de Freitas G
Cerebrovasc Dis. 2021; 50(3):245-261.
PMID: 33756459
PMC: 8089455.
DOI: 10.1159/000514155.
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis.
Syahrul S, Maliga H, Ilmawan M, Fahriani M, Mamada S, Fajar J
F1000Res. 2021; 10:34.
PMID: 33708378
PMC: 7934095.
DOI: 10.12688/f1000research.42308.1.
Coronavirus disease 2019 (COVID-19) can predispose young to Intracerebral hemorrhage: a retrospective observational study.
Lawton M, Alimohammadi E, Bagheri S, Bostani A, Vaziri S, Karbasforoushan A
BMC Neurol. 2021; 21(1):83.
PMID: 33607952
PMC: 7892324.
DOI: 10.1186/s12883-021-02109-8.
The three frontlines against COVID-19: Brain, Behavior, and Immunity.
Wang S, Su K, Pariante C
Brain Behav Immun. 2021; 93:409-414.
PMID: 33548496
PMC: 7857976.
DOI: 10.1016/j.bbi.2021.01.030.
